MR Angiography of Collateral Arteries in a Hind Limb Ischemia Model: Comparison between Blood Pool Agent Gadomer and Small Contrast Agent Gd-DTPA

The objective of this study was to compare the blood pool agent Gadomer with a small contrast agent for the visualization of ultra-small, collateral arteries (diameter<1 mm) with high resolution steady-state MR angiography (SS-MRA) in a rabbit hind limb ischemia model. Ten rabbits underwent unilateral femoral artery ligation. On days 14 and 21, high resolution SS-MRA (voxel size 0.49×0.49×0.50 mm3) was performed on a 3 Tesla clinical system after administration of either Gadomer (dose: 0.10 mmol/kg) or a small contrast agent (gadopentetate dimeglumine (Gd-DTPA), dose: 0.20 mmol/kg). All animals received both contrast agents on separate days. Selective intra-arterial x-ray angiograms (XRAs) were obtained in the ligated limb as a reference. The number of collaterals was counted by two independent observers. Image quality was evaluated with the contrast-to-noise ratio (CNR) in the femoral artery and collateral arteries. CNR for Gadomer was higher in both the femoral artery (Gadomer: 73±5 (mean ± SE); Gd-DTPA: 40±3; p<0.01) and collateral arteries (Gadomer: 18±4; Gd-DTPA: 9±1; p = 0.04). Neither day of acquisition nor contrast agent used influenced the number of identified collateral arteries (p = 0.30 and p = 0.14, respectively). An average of 4.5±1.0 (day 14, mean ± SD) and 5.3±1.2 (day 21) collaterals was found, which was comparable to XRA (5.6±1.7, averaged over days 14 and 21; p>0.10). Inter-observer variation was 24% and 18% for Gadomer and Gd-DTPA, respectively. In conclusion, blood pool agent Gadomer improved vessel conspicuity compared to Gd-DTPA. Steady-state MRA can be considered as an excellent non-invasive alternative to intra-arterial XRA for the visualization of ultra-small collateral arteries.

[1]  Dariusch R Hadizadeh,et al.  Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA. , 2008, Radiology.

[2]  W. Backes,et al.  Magnetic resonance angiography of collateral blood supply to spinal cord in thoracic and thoracoabdominal aortic aneurysm patients. , 2008, Journal of vascular surgery.

[3]  C. Longland Collateral Circulation in the Limb , 1953, Postgraduate medical journal.

[4]  Michael Simons,et al.  Arteriogenesis : Noninvasive Quantification with Multi – Detector Row CT Angiography and Three-dimensional Volume Rendering in Rodents 1 , 2006 .

[5]  D. Bilecen,et al.  MR angiography with blood pool contrast agents , 2007, European Radiology.

[6]  T L Chenevert,et al.  Magnetic resonance angiography with gadomer-17. An animal study original investigation. , 1998, Investigative radiology.

[7]  K. Kent,et al.  Contrast-Enhanced Peripheral MR Angiography from the Abdominal Aorta to the Pedal Arteries: Combined Dynamic Two-Dimensional and Bolus-Chase Three-Dimensional Acquisitions , 2001, Investigative radiology.

[8]  Martin Rohrer,et al.  Clinical blood pool MR imaging , 2008 .

[9]  J Lautrou,et al.  Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging. , 2001, Investigative radiology.

[10]  Debiao Li,et al.  Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. , 2001, Radiology.

[11]  J. Piek,et al.  Stimulation of collateral artery growth: travelling further down the road to clinical application , 2008, Heart.

[12]  J. Mintorovitch,et al.  Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.

[13]  J. V. van Engelshoven,et al.  Magnetic resonance angiography of collateral vessel growth in a rabbit femoral artery ligation model , 2006, NMR in biomedicine.

[14]  E. Nagel,et al.  MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery disease. , 2004, Radiology.

[15]  T. Leiner,et al.  Highly accelerated first‐pass contrast‐enhanced magnetic resonance angiography of the peripheral vasculature: Comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents , 2009, Journal of magnetic resonance imaging : JMRI.

[16]  K. Kent,et al.  Cross-sectional Pattern of Collateral Vessels in Patients with Superficial Femoral Artery Occlusion , 2001, Investigative radiology.

[17]  Philippe Robert,et al.  Comparison of Different Types of Blood Pool Agents (P792, MS325, USPIO) in a Rabbit MR Angiography-like Protocol , 2003, Investigative radiology.

[18]  R. Kreis,et al.  Leg ischemia: assessment with MR angiography and spectroscopy. , 2005, Radiology.

[19]  M. Port,et al.  P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[20]  B. Rutt,et al.  Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. , 2000, Radiology.

[21]  Wolfgang Ebert,et al.  Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[22]  F. Korosec,et al.  Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. , 2002, Radiology.

[23]  T. Leiner,et al.  Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: effect of contrast agent size. , 2010, Medical physics.

[24]  K. Nikolaou,et al.  MR angiography of infrapopliteal arteries in patients with peripheral arterial occlusive disease by using Gadofosveset at 3.0 T: diagnostic accuracy compared with selective DSA. , 2009, Radiology.

[25]  Tim Leiner,et al.  Reliability of pharmacokinetic parameters: Small vs. medium‐sized contrast agents , 2009, Magnetic resonance in medicine.

[26]  Philippe Leboulch,et al.  Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 , 2003, Nature Medicine.

[27]  T. Schroeder,et al.  Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium. , 2009, Academic radiology.